Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)

被引：0
|
作者：
Naim B Farah
Rami Ghanem
Mahmoud Amr
机构：
[1] King Hussein Cancer Center,From the department of surgery, section of Uro
[2] King Hussein Cancer Center,oncology
[3] Department of Surgical oncology,Section of Uro
来源：
BMC Urology | / 14卷
关键词：
Bladder cancer; BCG-RIVM; Intravesical; Maintenance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)
    Farah, Naim B.
    Ghanem, Rami
    Amr, Mahmoud
    [J]. BMC UROLOGY, 2014, 14
  • [2] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    [J]. MEDICAL ONCOLOGY, 2018, 35 (01)
  • [3] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor
    Husek, Petr
    Pacovsky, Jaroslav
    Chmelarova, Marcela
    Podhola, Miroslav
    Brodak, Milos
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216
  • [4] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [5] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    [J]. CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [6] SINGLE INSTILLATION OF MITOMYCIN C (MMC) PLUS BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Weiss, Brian
    Wein, Alan
    Malkowicz, S. Bruce
    Guzzo, Thomas
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E294 - E294
  • [7] UTILIZATION PATTERNS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR PATIENTS WITH HIGH-GRADE, NON-MUSCLE INVASIVE BLADDER CANCER
    Lenis, Andrew
    Litwin, Mark
    Saigal, Christopher
    Donin, Nicholas
    Lai, Julie
    Hanley, Jan
    Konety, Badrinath
    Chamie, Karim
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E8 - E8
  • [8] The Effectiveness of Bacillus Calmette-Guerin (BCG) Maintenance Treatment in Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Kim, B.
    Ha, J.
    Park, C.
    Kim, C.
    [J]. UROLOGY, 2012, 80 (03) : S215 - S216
  • [9] Real-world treatment patterns among patients with non-muscle invasive bladder cancer (NMIBC) treated with intravesical Bacillus Calmette-Guerin (BCG)
    Kumar, Neela
    Balaji, Hiremagalur Parthasarathy
    Emond, Bruno
    Manceur, Ameur M.
    Ghelerter, Isabelle
    Pilon, Dominic
    Lefebvre, Patrick
    Imran, Nida Shafaat
    Ellis, Lorie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 404 - 404
  • [10] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
12345